Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.63 USD | +0.06% | -3.40% | -7.02% |
06-05 | Catalyst Pharmaceuticals Insider Sold Shares Worth $276,735, According to a Recent SEC Filing | MT |
05-30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.02% | 1.84B | |
-0.35% | 91.94B | |
-3.16% | 38.74B | |
+64.83% | 26.66B | |
-13.98% | 15.32B | |
-5.40% | 13.3B | |
-11.38% | 11.65B | |
+156.85% | 10.37B | |
-49.84% | 10.12B | |
+2.32% | 9.06B |
- Stock Market
- Equities
- CPRX Stock
- News Catalyst Pharmaceuticals, Inc.
- Catalyst Pharmaceuticals Says Supplemental Application for Neuromuscular Disorder Treatment Accepted for Review by FDA